Preclinical development of 1B7/CD3, a novel antiTSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (vol 37, pg 2006, 2023)

LEUKEMIA(2024)

Cited 0|Views6
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined